2m 2m 2m 2m 2m 2m 2m
CRINETICS PHARMA (CRNX)
NASDAQ
$83.42-$0.25 (-0.30%)
Price as of Jul 14, 2026 4:00 AM EDT- $8.8BMarket Cap
- 153.39%1-Year Change
- BiotechnologyIndustry
CRINETICS PHARMA (CRNX)
$83.42-$0.25 (-0.30%)
CRNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $83.67 | ||
Change | +$0.09 (+0.11%) | ||
Open | $83.66 | ||
High | $83.69 | ||
Low | $83.59 | ||
Previous Close | $83.58 | ||
Volume | 6,258,260 | ||
30-Day Average Volume | 7,759,963 | ||
1-Week Change | 99.07% | ||
1-Month Change | 142.73% | ||
1-Year Change | 153.39% | ||
3-Year Change | 308.54% | ||
5-Year Change | 318.14% | ||
Fundamentals | |||
Shares Outstanding | 105.8M | ||
Total Assets | $1.4B | ||
Market Cap | $8.8B | ||
Enterprise Value | $8.7B | ||
Period: QTR TTM FY | |||
Revenue | $10.3M | ||
Net Income | -$127.8M | ||
Free Cash Flow | -$125.5M | ||
EBIT | -$127.8M | ||
EBITDA | -$126.7M | ||
Net Working Capital | $1.3B | ||
EPS | -$1.23 | ||
Enterprise Value/EBITDA | -69 | ||
Enterprise Value/Revenue | 847 | ||
P/B | 7 | ||
P/E | -68 | ||
PEG | -14 | ||
Price/Free Cash Flow | -70 | ||
Price/Operating Cash Flow | -71 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue